Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

Completed · Phase 4

Conditions studied: Migraine

In brief

To assess the efficacy and safety of eletriptan for migraine headaches in subjects who were not satisfied with rizatriptan therapy

Key facts

Study ID

NCT00632385

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

127

Starts

2003-01-01

Expected to finish

2003-08-01

Last updated by the study team

2021-01-27

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of migraine headache according to International Headache Society criteria and migraine headaches for at least 1 year
• Eletriptan naive
• Previously treated with rizatriptan and failed to achieve a satisfactory response within the past 12 months

You may not qualify if…

• Non-migraine headaches on average more than 6 days per month or have less than 24 hours of freedom from headache between migraine attacks
• Migraine attacks that are atypical or chronic daily headaches
• A history of migraine with prolonged aura, familial hemiplegic migraine, basilar migraine, migrainous infarction, migraine aura without headache, migraine with acute onset aura

Where it is running

• Pfizer Investigational Site — Irvine, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — San Francisco, California, United States
• Pfizer Investigational Site — Plantation, Florida, United States
• Pfizer Investigational Site — St. Petersburg, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Marietta, Georgia, United States
• Pfizer Investigational Site — South Bend, Indiana, United States
• Pfizer Investigational Site — Milford, Massachusetts, United States
• Pfizer Investigational Site — Chesterfield, Missouri, United States
• Pfizer Investigational Site — Springfield, Missouri, United States
• Pfizer Investigational Site — Greensboro, North Carolina, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Eugene, Oregon, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — Alexandria, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.